Protection that Simplifies Adherence
Simplify Compliance with 12 weeks* of Flea and Tick Protection
FEWER DOSES MEANS MORE CONVENIENCE FOR PET OWNERS
Bravecto (fluralaner) offers nearly a full year of protection with 4 doses–instead of treating 12 times as you would with monthly protection
FEWER POTENTIAL GAPS IN PROTECTION1-4
Fewer doses per year, for both oral and topical treatment options, means less chance of pet owners forgetting and missing a dose
AVAILABLE BY PRESCRIPTION AT VETS ONLY
Providing trusted recommendations, that help the pets in your care, brings business back to your hospital
Hear How Veterinarians are Enhancing Pet Owner Compliance with Bravecto®
“There’s no better joy than to see someone who doesn’t have fleas in their household.” Dr. Randal Bennett, Texas
Dr. Randal Bennett
Texas
Bravecto® Chew for Dogs
Help dog owners understand the difference of Bravecto Chew so you can improve compliance:
- Bravecto (fluralaner) as an chew is an easy-to-administer treatment for dogs that don’t like to sit still for topicals
- The chew is well tolerated and palatable, making treatment less stressful for dog and pet owner
- Dogs love the tasty pork flavor – in a US field study, 93.2% of dogs ate the Bravecto chewable tablet voluntarily1,4
- The prolonged, systemic flea and tick protection provides 12-week* dosing period1,4
- Washing, swimming and grooming will not affect Bravecto Chew’s efficacy
One chew per weight band1
†Dogs over 123.0 lb. should be administered the appropriate combination of chews.
Bravecto Topical for Dogs and Cats
Help pet owners understand the difference of Bravecto Topical so you can improve compliance:
- The innovative formula is applied topically but works systemically like the chew medication2,3
- The Twist’n’Use™ applicator has a hassle-free cap that does not need to be fully removed, making it easy to use with finicky felines and dogs2,3
- With fewer potential gaps in protection for 12 weeks* than with monthly topical treatments, it helps with the challenge of poor compliance2,3,5
- Bravecto Topical for Dogs resists repeated swimming/bathing for its full 12-week* dosing period.2
- There are less chances to forget with up to two-thirds less often dosing than monthly treatments.2,3
One application per weight band2
†Dogs over 123.0 lb. should be administered the appropriate combination of tubes.
§Cats over 27.5 lb. should be administered the appropriate combination of tubes.
Why Veterinarians Trust the Safety of Bravecto
FDA approved and veterinarian recommended, Bravecto Chew and Topical Solution for Dogs are approved for pregnant, breeding, and lactating dogs.1,2,5,6
Bravecto is also approved for use in dogs 6 months of age and older, and weighing 4.4 pounds or greater.1,2
Bravecto Topical Solution for Cats is approved for cats and kittens 6 months of age and older and weighing 2.6 pounds or greater.3
See more safety information:
Advantages of Bravecto®:
Offer Pet Owners Savings
One dose of Bravecto lasts 12 weeks* compared to monthly products. That already makes it a cost-effective option for pet owners. But now, you can help pet owners save even more on flea and tick control with Bravecto.
The Satisfaction Difference
We want to make sure your clients receive the results they expect. If your clients do not achieve the level of flea and tick control that was desired from the topical or oral treatments, please call our team of flea and tick control experts to see if they qualify for our Bravecto Satisfaction Guarantee. Our team will work with you to ensure that your clients are satisfied.
CONTACT US ABOUT THE 12-WEEK* DIFFERENCE
Contact us for more information about Bravecto for your hospital.
We’ll answer any questions, and help you start prescribing Bravecto for the dogs and cats in your care.
For technical assistance or to report a suspected adverse drug reaction, contact Merck Animal Health at 1-800-224-5318.
This site is intended for veterinary professionals. Vist our website for pet parents.
*BRAVECTO kills fleas and prevents flea infestation. Bravecto Chew and Bravecto Topical for Dogs kills ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks and also kills lone star ticks for 8 weeks. Bravecto Topical for Cats kills ticks (black-legged tick) for 12 weeks and American dog ticks for 8 weeks.
IMPORTANT SAFETY INFORMATION:
BRAVECTO has not been shown to be effective for 12-weeks’ duration in puppies or kittens less than 6 months of age. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. BRAVECTO Chew: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO is not effective against lone star ticks beyond 8 weeks of dosing. Seizures have been reported in dogs receiving isoxoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. BRAVECTO Topical Solution for Dogs: The most commonly reported adverse reactions include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. Seizures have been reported in dogs receiving isoxoline class drugs, even in dogs without a history of seizures. Use caution in dogs with a history of seizures or neurologic disorders. BRAVECTO Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of BRAVECTO has not been established in breeding, pregnant and lactating cats. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders.
References:
1. Bravecto Chew for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2014.
2. Bravecto Topical Solution for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2016.
3. Bravecto Topical Solution for Cats [prescribing information]. Madison, NJ: Merck Animal Health; 2016.
4. Freedom of Information Summary, NADA 141-426. Approved May 15, 2014.
5. Freedom of Information Summary, NADA 141-459. Approved 2016.
6. Walther FM, Allan MJ, Roepke RKA, Nuernberger MC. Safety of fluralaner chewable tablets (Bravecto™), a novel systemic antiparasitic drug, in dogs after oral administration. Parasites & Vectors (2014) 7:87.
7. Walther FM, Allan MJ, Roepke RKA, Nuernberger MC. Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) collies after oral administration. Parasites & Vectors (2014) 7:86.
8. Burgio et al. Parasites & Vectors (2016) 9:626.
9. Taenzler et al. Parasites & Vectors (2014) 7:567.
10. Wengenmayer et al. Parasites & Vectors (2014) 7:525.
Order Bravecto® for your practice